FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/12/060976 [Registered on: 29/12/2023] Trial Registered Prospectively
Last Modified On: 20/12/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device
Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Crossover Trial 
Public Title of Study   Effect of a brain stimulation technique on activity of brain regions in people with mild cognitive impairment. The purpose of this study is to test a new brain stimulation technique for improving memory problems in people with mild cognitive impairment. 
Scientific Title of Study   Effect of transcranial theta-gamma stimulation technique on default mode network activity and connectivity in individuals with mild cognitive impairment: A pilot randomized placebo-controlled trial. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shivani Mhaskar 
Designation  Post graduate student 
Affiliation  Manipal College of Health Professions 
Address  Department of Physiotherapy, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, Karnataka, India

Udupi
KARNATAKA
576104
India 
Phone  9967942974  
Fax    
Email  shivani7.mhaskar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Divya Adhia 
Designation  Assistant Professor-Senior scale 
Affiliation  Manipal College of Health Professions 
Address  Department of Physiotherapy, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, Karnataka, India

Udupi
KARNATAKA
576104
India 
Phone    
Fax    
Email  adhia.divya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Shivani Mhaskar 
Designation  Post graduate student 
Affiliation  Manipal College of Health Professions 
Address  Department of Physiotherapy, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, Karnataka, India


KARNATAKA
576104
India 
Phone  9967942974  
Fax    
Email  shivani7.mhaskar@gmail.com  
 
Source of Monetary or Material Support  
Manipal College of Health Professions Madhav Nagar, Eshwar Nagar, Manipal, Karnataka 576104, India 
 
Primary Sponsor  
Name  Shivani Mhaskar 
Address  Department of Physiotherapy, Manipal College of Health Professions, Manipal, Karnataka 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Manikandan Natarajan  Kasturba Hospital  Neuromotor Control Room 3rd floor CTC block Kasturba Hospital Manipal 576104
Udupi
KARNATAKA 
9886898064

mani.kandan@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee 1  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G30-G32||Other degenerative diseases of the nervous system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Sham stimulation  Actisham protocol developed by Neuroelectrics will be used to create the same skin sensation as the active stimulation. The total duration of the Actisham protocol will be a single session of 30 minutes. A 60s ramp up and 60s ramp down current will be applied at the beginning of the stimulation session and no current will be applied for the remainder of the session but only EEG will be recorded. Thus the sham session duration will thus be equivalent to the active stimulation phase session and will help blind the participants appropriately for the treatment procedure.  
Intervention  Transcranial electrical stimulation.  The transcranial theta-gamma noise stimulation targeting posterior cingulate cortex and parahippocampus will be delivered for a single session of 30 min continuously by a researcher experienced in neuromodulation techniques. A 60s ramping up current and similarly a 60s ramping down current will be used at the start and the end of each treatment session respectively. The gamma noise stimulation will be overlaid on the theta sinusoidal waveform. The total duration of the intervention will be 30 mintues. 
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. English or Kannada speaking
2. Subjective memory complaints
3. 0.5 score on Clinical Dementia Rating
4. 18-25 score on Montreal Cognitive assessment
5. Preserved daily functions
6. Without symptoms of Dementia
7. Presence of a care-taker for reporting of memory problems of the participant. 
 
ExclusionCriteria 
Details  1. Cognitive decline due to causes or conditions other than amnestic mild cognitive impairment
2.Enrolment in other tentative drug or trial study during the period of trial
3.History of seizures or epilepsy or other neurological disorders
4. Migraine or vertigo
5.Dizziness or balance disorders
6. Any other psychiatric conditions like schizophrenia or bipolar disorders or personality disorders or major depressive disorders
7. Substance abuse disorders
8.Cardiac pacemakers or metal implants in head and neck regions 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Feasibility measures:
-Recruitment rate
-Drop-out rates
-Acceptibility of the intervention
- Safety of the intervention using Adverse Effects Questionnaire
2.Resting state EEG
 
1. Before intervention
2.Immediately after intervention
 
 
Secondary Outcome  
Outcome  TimePoints 
1. Montreal Cognitive Assessment
2.Trail Making Test A and B
3. Pattern Recognition Memory 
1. Before intervention
2. Immediately after intervention 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Alzheimer’s Disease (AD), most commonest form of Dementia, which is a substantial worldwide problem and a growing health challenge. People with amnestic mild cognitive impairment (MCI) are more likely to progress to AD (10-15% per year), when compared to normal older people (1-3% per year). Treatments targeted at the MCI stage could thus potentially prevent or delay the transitions to the AD. Dysfunctional connectivity in resting state brain networks has been shown by a number of functional brain imaging studies in people with AD, that are predictive of progression from MCI to AD. Particularly, structural and functional alterations in posterior cingulate cortex (PCC) and parahippocampus (PHC) have been demonstrated very early in AD and are associated with cognitive dysfunctions. The individuals with progressive MCI demonstrates reduction in the theta–gamma cross frequency coupling when compared to individuals with stable MCI. Thus specifically targeted interventions focusing on increasing the functional connectivity and the theta-gamma cross-frequency- coupling between the PCC and PHC could likely improve clinical outcomes, with greater effect.

The primary objectives of this study are to explore the effect of the transcranial theta-gamma noise stimulation technique on the activity, functional connectivity, and the cross-frequency-coupling of the targeted brain regions (PCC and PHC) in people with mild cognitive impairment, and to determine the feasibility of the transcranial theta-gamma noise stimulation technique for treatment of mild cognitive impairment. The secondary objective of the study is to determine the estimates of changes in the cognitive outcomes following targeted transcranial theta-gamma noise stimulation technique in people with MCI.

 
Close